The potential role of the mediterranean diet on clinical outcomes in patients with inflammatory bowel disease: A systematic review.
Ahmed Hosney Nada, Mohamed Mabrouk Ghonaim, Abdelrahman Awad et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review evaluated the impact of the Mediterranean diet (MedDiet) on clinical outcomes in patients with inflammatory bowel disease (IBD). It included 12 studies with 1615 patients, revealing that while observational studies suggested benefits such as improved quality of life and lower inflammatory markers, randomized controlled trials showed mixed and generally non-significant effects on inflammatory biomarkers.
Key findings
- Observational studies indicated beneficial associations between MedDiet adherence and lower inflammatory markers.
- Greater adherence to the MedDiet was linked to improved quality of life in IBD patients.
- Randomized controlled trials reported mixed effects on inflammatory biomarkers, generally non-significant.
Why it matters
Understanding the potential benefits of the Mediterranean diet in IBD patients could inform dietary recommendations and improve patient outcomes, particularly in managing inflammation and enhancing quality of life.
What to keep in mind
Substantial heterogeneity in study designs, populations, and outcome measures limited the strength of the evidence and precluded meta-analysis.